Crossmark

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Published Print: 2020-09

Authors

Liu, Tianxiao

Luo, Songyuan

Libby, Peter

Shi, Guo-Ping
License Information

Text and Data Mining valid from 2020-09-01

Text and Data Mining valid from 2020-09-01
More Information

This article is maintained by: Elsevier

Article Title: Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Journal Title: Pharmacology & Therapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharmthera.2020.107587

Content Type: article

Copyright: © 2020 Elsevier Inc. All rights reserved.

Document is current